IPOs – INITIAL PUBLIC OFFERINGS

IPO's are a major "movement of money" theme creating opportunities for employment seekers at all levels to participate in the growth/expansion of a company. New money equals new opportunities.

Many companies seek an infusion of money from the public through registration with the Security Exchange Commission and an investment banking organization such as a stock broker. A company is promoted by a broker setting the stage for an initial opportunity for the general public to participate in a private company's anticipated growth by buying stock in the company. The infusion of money allows the company to make various improvements in their operating, marketing, research and development, or manufacturing facilities, or simply to pay down debt allowing the company to become profitable again. Most importantly, the infusion of money will allow the company to attract and retain competent employees. 

Being aware of IPO activity is an important part of career management. By contacting the decision-maker at the right time and the right place, the astute job seeker can minimize the competition and find, or create, the ideal position. See your consultant for details.

Latest Pricings
When a company that has filed with the SEC begins trading (goes public), it completes the IPO cycle. The following companies are now trading. They are provided in reverse chronological order (most recent first).

Please click on “edit” and then “find” to locate specific companies, locations, dates, etc.

Back


IPOs – INITIAL PUBLIC OFFERINGS

Max Re Capital Ltd.

Ascot House, 28 Queen St.
Hamilton HM 11, Bermuda 

Phone: 441-296-8800
Fax: 441-296-8811

http://www.maxre.bm 

Domiciled in Bermuda, Max Re Capital provides reinsurance for property/casualty and life as well as annuity markets through its Max Re subsidiary. Max Re underwrites individual and group life insurance products and offers coverage for workers' compensation, employers' liability, medical malpractice, property damage, and other casualty liability risks. The company has a joint reinsurance venture (Grand Central Re) with German banking biggie Bayerische Hypo- und Vereinsbank. Max Re Capital plans to expand in Europe (about 20% of total revenue) through Dublin-based Max Re Europe. 

Top Competitors
American Re | Munich Re | Reinsurance Group of America 
   
IPO Information 
Date went public: Aug 14, (No new pricings for September )
Filing Date: May 31,
Proposed offer price: $16.00 to $16.50
Actual offer price: $16.00
First day open: $15.80
First day close: $15.50
Shares offered (mil.): 12.0
Offering amount (mil.): $192.0
Post-offering shares (mil.): 49.5
Underwriters:
Morgan Stanley & Co. Incorporated
Salomon Smith Barney
Goldman, Sachs & Co.
Banc of America Securities LLC
Dresdner Kleinwort Wasserstein Securities LLC
Key Numbers
Company Type: Public 

Nasdaq: MXRE (full quote) 

Fiscal Year-End: December 

Sales (mil.): $451.3 

Net Inc. (mil.): $8.7 

Employees: 22 
Key People
Chairman, President, and CEO
Robert J. Cooney 

Deputy Chairman
Zack H. Bacon III 

EVP and CFO
Keith S. Hynes 

EVP and Managing Director, Max Re Europe Limited
Luc Gagnon 

EVP, Property and Casualty Operations
W. Dave Brining
Back

Mykrolis Corporation

1 Patriots Park
Bedford, MA 01730 

Phone: 877-695-7694
Fax: 877-695-7639

http://www.mykrolis.com 

Mykrolis cleans out the contaminants. A subsidiary of filtration products maker Millipore, Mykrolis (formerly Millipore MicroElectronics) manufactures equipment that delivers, filters, and controls gases and liquids used in the production of semiconductors, fiber-optic cables, flat-panel displays, and gas lasers. Mykrolis also generates sales from servicing equipment. The company's direct sales force sells primarily to Asian and North American semiconductor manufacturers, including Samsung Electronics and Motorola. Parent Millipore has spun off 20% of Mykrolis to the public and the rest to Millipore shareholders in the form of a dividend. 

Top Competitors
MKS Instruments | Pall | USFilter 
  

IPO Information 
Date went public: Aug 10
Filing Date: Mar 16

Proposed offer price: $15.00 to $17.00
Actual offer price: $15.00
First day open: $17.25

Shares offered (mil.): 7.0
Offering amount (mil.): $105.0
Post-offering shares (mil.): 40.55

Underwriters:
Banc of America Securities LLC
Salomon Smith Barney
ABN AMRO Rothschild
Key Numbers
NYSE: MYK (full quote) 

Fiscal Year-End: December 

Sales (mil.): $355.5 
1-Yr. Sales Growth: 72.3% 

Net Inc. (mil.): $37.4 
1-Yr. Net Inc. Growth: 1,038.3% 

Employees: 1,130 
Key People
Chairman and CEO
C. William Zadel 

President and COO
Jean-Marc Pandraud 

President and CEO, Nihon Millipore MicroElectronics
Hideo Takahashi 

VP and CFO
Bertrand Loy 

VP, Secretary, and General Counsel
Peter W. Walcott 
Back

Omnicell, Inc.

1101 E. Meadow Dr.
Palo Alto, CA 94303 

Phone: 650-251-6100
Fax: 650-843-6262

http://www.omnicell.com 

If your health care products supply is bottled up like the cotton in your aspirin, there's Omnicell. Formerly Omnicell Technologies, the company provides procurement and inventory management systems for some 1,100 hospitals, nursing homes, and other health care facilities. The company's automation systems include computerized cabinets that help track regulatory compliance and the dispensation of pharmaceuticals and supplies. Products include OmniBuyer, which automates the requisition and approval process, and DecisionCenter, which offers trend analysis and decision support. The company also operates the MedCenterCity information Web site for health care professionals. 
  

Top Competitors
AmeriSource | Cardinal Health | 
McKesson General Medical 
IPO Information 
Date went public: Aug 7
Filing Date: Mar 14

Proposed offer price: $7.00 to $9.00
Actual offer price: $7.00
First day open: $7.20
First day close: $9.62

Shares offered (mil.): 6.0
Offering amount (mil.): $42.0
Post-offering shares (mil.): 20.4

Underwriters:
U.S. Bancorp Piper Jaffray
CIBC World Markets
SG Cowen
Key People
Chairman
Randall A. Lipps 

President and CEO
Sheldon D. Asher 

VP of Finance and CFO
Robert Y. Newell IV 

VP of Engineering
John D. Higham 

VP of Sales and Field Operations
S. Michael Hanna 
Back

Bunge Limited
50 Main St., 6th Fl.
White Plains, NY 10606 

Phone: 914-684-2800
Fax: 914-684-3499

http://www.bunge.com 

Even after cutting back on consumer foods, Bunge Limited (formerly Bunge International) is still sizable. The conglomerate is a leading global soybean exporter, and, through subsidiary Bunge North America, is the US's #3 food processor (after ADM and Cargill). Bunge also owns Latin America's largest fertilizer producer. To focus on its soybean, grain trading, and fertilizer businesses, Bunge sold all of its consumer food processing firms, except Bunge Alimentos (margarine maker and soybean processor). Founded in 1818, Bunge was held mostly by the families descended from founder Johann Peter Gottlieb Bunge until it went public in August . 

Top Competitors
ADM | Cargill | IMC Global 
   

IPO Information 
Date went public: Aug 2
Filing Date: Jul 13
Proposed offer price: $16.00 to $18.00
Actual offer price: $16.00
First day open: $16.00
First day close: $16.00
Shares offered (mil.): 17.6
Offering amount (mil.): $281.6
Post-offering shares (mil.): 81.98
Underwriters:
Morgan Stanley & Co. Incorporated
Credit Suisse First Boston
Deutsche Banc Alex. Brown
Merrill Lynch & Co.
Prudential Securities, Inc.
Salomon Smith Barney
Key Numbers
NYSE: BG

· · #247 in Hoover's 500

Fiscal Year-End: December 

Sales (mil.): $9,667 
1-Yr. Sales Growth: 19.7% 

Net Inc. (mil.): $12 

Employees: 18,148 
Key People
Chairman and CEO
Alberto Weisser 

Deputy Chairman
Jorge Born Jr. 

CFO
William M. Wells 

President, Serrana
Mario Barbosa 

President and CEO, Bunge Fertilizantes S.A.
Maria A. Barbosa Neto
Back